|
 |
Rafael Alfonso
Admission: Fall 2007
MD, Universidad del Rosario, Colombia
MSc, Universidad Autonoma de Barcelona, Spain
Research Interest: Evaluation of health policies, pharmacoeconomics and outcomes research in Latin American countries.
|
Deborah Atherly, PhD Candidate
Admission: Fall 1999
MPH, University of Washington
BS, Pharmacy, University of Washington
Dissertation Title: Evaluation of the Costs and
Health Effects of the Syphilis Rapid Immunochromatographic Strip
(ICS) Test in Antenatal Screening Programs in Mozambique
|
Joseph Babigumira
Admission: Fall 2006
MS, Health Services Research, Case Western Reserve University
MBChB, Medicine and Surgery, Mbarara University, Uganda
Research Interests : To conduct cost-effectiveness
research and to influence health policy in Uganda and other sub-Saharan
countries
|
Mindy Cheng
Admission: Fall 2006
MS, Healthcare Administration, California State University, East
Bay
BS, Microbiology, University of Michigan
Research Interests: Orphan drugs- economics and outcomes, pharmacoeconomics, health policy analysis, infectious disease diagnosis and treatment
|
Jamie Cross, PhD Candidate
Admission: Fall 2004
Fellow in Drug Development Science (Georgetown University)
MS Immunology (University of California, Davis)
BS Biology and French (Tufts University)
Dissertation Title: A Case Study and Policy Analysis of Novel Quantitative Methods for Drug Risk-Benefit Assessment in Regulatory Decision-Making
Research Interests: Risk-benefit analysis, decision-analysis, drug regulation and policy, improving the efficiency of clinical trial design and analysis for decision-making.
|
Bernardo Goulart
Admission: Fall 2008
MD, Universidade Federal do Rio de Janiero
Research Interests: Clinical outcomes in lung and head and neck cancers; cost-effectiveness of lung and head and neck cancer therapies; cancer clinical trials.
|
Katie Gries
Fellowship: 2008-2010
University of Washington/Allergan
Post-Doctoral Fellowship
PharmD, University of Southern California
Research Interests: Pharmaceutical outcomes; economic benefit of evidence based medicine, quality of life research that relates to drug treatment, cost-effectiveness analyses applies to oncology management
|
Ryan Hansen
Fellowship: 2007-2011
University of Washington/Abbott Laboratories
Pre-Doctoral Fellowship
PharmD, University of Washington
Research Interests: Health economics, cost-effectiveness analyses, health and disease state modeling.
|
Elizabeth James, PhD Candidate
Admission: Fall 2004
PharmD, University of Texas, Austin
BS Biomedical Sciences, Texas A&M University
Dissertation Title: Evaluation of a Prescription Drug Pay-for-Performance Program: Impact on prescribing trends, budget and patient outcomes
Research Interests: Pharmaceutical policy, pharmacy
practice, health insurance prescription benefit structure, clinical
trials
|
Norio Kasahara
Admission: Fall 2008
BS, Pharmacy, Tokyo University of Pharmacy & Life Sciences
MPH, Johns Hopkins University
Research Interests: Health policy analysis and pharmaceutical outcomes research; pharmaceutical regulations and policies, pharmacoeconomics, effectiveness analysis of pharmaceutical interventions, and global health.
|
Joshua Roth
Admission: Fall 2008
MHA, University of Washington
BS, Experimental Psychology and Sociology, Union College,Schenectady, NY
Research Interests: Health technology assessment, Cost-effectiveness analysis in cancer therapeutics, Effects of changes in policy on cost and utilization of prescription medications
|
D. Eldon Spackman
Admission: Fall 2005
MA, Health Economics, University of Calgary
BA Economics, University of Calgary
Dissertation Title: Health Economics Research in Alzheimer’s Disease: Support for Dependence as an Economic Outcome and the Development of a Model Evaluating the Cost-Effectiveness of Screening
Research Interests: cost-effectiveness analyses, modeling
(Markov and Discrete Event Simulation) and health economics.
|
Jonathan Watanabe
Fellowship: 2007-2009
University of Washington/Allergan
Post-Doctoral Fellowship
PharmD, University of Southern California
MS, University of Washington
Thesis Title: Cost Analysis for Interventions for Antimuscarinic Refractory Patients with Overactive Bladder
Research Interests: Payer Cost and Reimbursement Analysis, Patient Reported Outcomes and Dossier submission to FDA, Health Related Quality of Life and Utility assessment, Impact of Drug-Drug Interactions on Care
|
Catherine Waweru
Admission: Fall 2006
MSc, Clinical Pharmacy, University
of London
BSc, Pharmacy, University of Nairobi, Kenya
Research Interests: To create policies that will
improve access to necessary pharmaceuticals and health services
for the the people of Kenya - particularly women and children.
|
Heidi Wirtz
Admission: Fall 2008
BS, University of Iowa
MS, University of Iowa
PharmD, Creighton University
Reseach Interests: Cost-effectiveness analysis of biologics and health care technology, clinical trial design, Regulatory decision-making.
|
Jelena Zurovac
Admission: Fall 2006
PhD Student, Economics, University of Washington
BA, Economics, Smith College
Research Interests: Health and development economics,
cost-effectiveness analysis
|
|
